Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy

Table 4

Decreasing and nondecreasing total chimerism between day 30 and day 100.

	Decreasing (%)	Nondecreasing (%)	value
FluBu4 with no PK	18 (52.9)	16 (47.1)	.04
FluBu4 with PK	5 (23.8)	16 (76.2)
BuCy	6 (26.1)	17 (73.9)

Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; PK, pharmacokinetics.